ICNet® Systems, Inc., which provides infection surveillance and pharmacy stewardship software to more than 1,200 hospitals globally, and Visante®, Inc., a leader in medications management and infectious disease consulting, today announced a partnership to offer hospitals a comprehensive solution to help preserve the last line of defense against life-threatening bacteria.
This strategic alliance is being formed to address the complex clinical and data analysis
challenges associated with antimicrobial stewardship and infectious disease management. It combines ICNets powerful clinical decision support software with Visantes depth of clinical expertise and hospital operating experience to promote the proper use of medications that treat infections.
ICNet will provide its suite of Agile Surveillance software solutions, which include:
- Comprehensive community and hospital-acquired infection surveillance.
- ABX Alert, a real-time clinical decision support application that interfaces with existing
information systems to ensure appropriate prescribing of antibiotics; detects and
prevents adverse drug events for all classes of drugs; and provides accurate and
powerful reports on a wide range of quality-of-care metrics, including auditing of doctors
adherence to prescribing protocols and the efficacy of interventions.
With its experienced team of physicians, pharmacists, and hospital operating executives,
Visante will provide clinical advisory services tailored to each hospitals unique issues with
bacterial resistance. Visante consultants conduct an extensive review of data, including an
onsite visit to assess current bacteriology, prescribing habits, antibiotic use and cost,
antimicrobial resistance and current stewardship efforts. Visante benchmarks the data against similar settings to discover the extent of resistance and the reasons driving it.
Weve been working to provide health systems with the data they need to improve clinical surveillance and antimicrobial stewardship across their operations, says Adam Boris, chief executive officer of ICNet Systems. Given the nature of the challenges facing healthcare today, it makes sense to partner with a company in Visante, which can help providers make the best use of that data through a structured, effective stewardship program.
Adds Michael Flagstad, Visante CEO: Through our strategic alliance, Visante and ICNet will be able to provide clients with increased ability and speed to identify anti-infective best practices and uncover opportunities to improve the way these medicines are used. In an era when payment is at risk over hospital-acquired infections and readmissions and regulators are intensifying scrutiny of medication management, a systematic approach to antibiotic use in hospitals is critical.
The two companies will work together to identify hospitals that would benefit from a combined ICNet/Visante approach. They will also share opportunities to co-market ICNet solutions and Visante consulting expertise.
Source: ICNet
Â
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.